Dapagliflozin enhances systolic and diastolic function in concordance with clinical response in patients with left ventricular dysfunction.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-05-01
DOI
https://doi.org/10.26355/eurrev_202505_37222
Primary Topic
Cardiovascular Function and Risk Factors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dapagliflozin enhances systolic and diastolic function in concordance with clinical response in patients with left ventricular dysfunction.

Safwat Ibrahim Alnahrawi, Hussein Sultan, Rania Sarhan, Abdullah Salah Alanazi et al.
PubMed
Cardiovascular Function and Risk Factors
article

Dapagliflozin enhances systolic and diastolic function in concordance with clinical response in patients with left ventricular dysfunction.

Safwat Ibrahim Alnahrawi, Hussein Sultan, Rania Sarhan, Abdullah Salah Alanazi, Bakry Ibrahim, Heba F. Salem, Ali F. Altebainawi, Abdulaziz Ibrahim Alzarea, Bassem Zarif, Ayman Moharram, Ahmed Essam Abou Warda, Tariq Ghazi Alsahli, Josiana Duarte, Mohamed Nabil Salem, Mohammed Alrashdi, K Kamel Megalaa
article en

Abstract

No abstract available for this paper.
PubMedVol. 29(5)
October 6 University (EG)
Openalex Percentile: Top 78%
Cardiovascular Function and Risk Factors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.